ClinicalTrials.gov
ClinicalTrials.gov Menu

Characterizing and Comparing the Profile of Microorganisms From Specific Body Sites and Environmental Surfaces in Newly Disinfected Patient Rooms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01803100
Recruitment Status : Completed
First Posted : March 4, 2013
Last Update Posted : October 26, 2015
Sponsor:
Collaborators:
University of North Carolina, Chapel Hill
Durham VA Medical Center
Information provided by (Responsible Party):
Duke University

February 27, 2013
March 4, 2013
October 26, 2015
January 2013
July 2015   (Final data collection date for primary outcome measure)
Changes in the Profile of Epidemiologically-Important Organism [ Time Frame: Day 3, 7 and each week after enrollment ]
Same as current
Complete list of historical versions of study NCT01803100 on ClinicalTrials.gov Archive Site
Time to Change in the Profile of Epidemiologically Important Organism [ Time Frame: Day 3, 7 and each week after enrollment ]
Same as current
Not Provided
Not Provided
 
Characterizing and Comparing the Profile of Microorganisms From Specific Body Sites and Environmental Surfaces in Newly Disinfected Patient Rooms
Study of the Temporal Profile and Bi-directional Transmission of Microorganisms Between Patients and Environmental Surfaces.

Overall Aim: To describe and to assess the change in the temporal profile and transmission of microorganisms between patients and environmental surfaces after admission into a newly disinfected room.

Study Activities: Investigators will prospectively and concurrently perform microbiological sampling of body sites (nose, throat, axillae, perineal and wounds) high touch surfaces (e.g. bedside rail, bed surface, toilet seat, IV pump and tray table) for consented adult patients admitted to freshly cleaned patient rooms. The microbiological sampling of body sites is already performed in many units of the hospital as standard of care. Infection and readmission related data from enrolled patients will be collected for upto 1 year after enrollment.

Data analysis: Standard surveillance for hospital-acquired infections will be performed by the infection control group of the hospital. The identity and the nature of micro-organisms colonizing the high touch surfaces of rooms and of patient's body sites will be determined and compared. Risks involved is no more than minimal risk.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
Swabs from nares, oropharynx, axillae, peri-rectal. Fecal specimens
Non-Probability Sample
The cohort will be selected from hospitalized inpatients who are admitted into freshly-cleaned patient rooms and provides consent to participate in this study.
Bacterial Infection
Other: No intervention
There is no intervention in this trial
Other Name: There is no intervention in this trial
Hospitalized inpatients
Inpatients newly admitted into freshly-cleaned rooms.
Intervention: Other: No intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
80
Same as current
October 2015
July 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Eligible patients who provide informed consent.

Exclusion Criteria:

  • Pediatric patients under 18 years of age,
  • Patients who cannot or do not provide consent
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01803100
Pro00036470
203-1049 ( Other Grant/Funding Number: CDC )
No
Not Provided
Not Provided
Duke University
Duke University
  • University of North Carolina, Chapel Hill
  • Durham VA Medical Center
Principal Investigator: Luke Chen, MBBS MPH Duke University
Duke University
October 2015